These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 3525245
1. [Clinical investigation on the mechanism of glucose intolerance in Cushing's syndrome]. Takeda N, Yasuda K, Horiya T, Yamada H, Imai T, Kitada M, Miura K. Nihon Naibunpi Gakkai Zasshi; 1986 May 20; 62(5):631-48. PubMed ID: 3525245 [Abstract] [Full Text] [Related]
2. Insulin secretion, insulin sensitivity and glucose-mediated glucose disposal in Cushing's disease: a minimal model analysis. Page R, Boolell M, Kalfas A, Sawyer S, Pestell R, Ward G, Alford F. Clin Endocrinol (Oxf); 1991 Dec 20; 35(6):509-17. PubMed ID: 1769133 [Abstract] [Full Text] [Related]
5. Changes in glucose metabolism based on 75-g oral glucose tolerance tests before and after surgery for adrenal Cushing's syndrome. Tsurutani Y, Miyoshi K, Inoue K, Takiguchi T, Saito J, Omura M, Nishikawa T. Endocr J; 2019 Mar 28; 66(3):207-214. PubMed ID: 30674738 [Abstract] [Full Text] [Related]
6. Incompatibility between fasting and postprandial plasma glucose in patients with Cushing's syndrome. Otsuki M, Kitamura T, Tamada D, Tabuchi Y, Mukai K, Morita S, Kasayama S, Shimomura I, Koga M. Endocr J; 2016 Nov 30; 63(11):1017-1023. PubMed ID: 27498594 [Abstract] [Full Text] [Related]
7. [Forty-one cases of Cushing's syndrome: a comparison between Cushing's syndrome (adrenal adenoma) and Cushing's disease (adrenal hyperplasia)]. Komiya I, Takasu N, Ohara N, Nagasawa Y, Ohtsuka H, Asawa T, Yamada T. Nihon Naibunpi Gakkai Zasshi; 1992 Jun 20; 68(6):607-22. PubMed ID: 1633931 [Abstract] [Full Text] [Related]
8. Adrenal incidentaloma: a new cause of the metabolic syndrome? Terzolo M, Pia A, Alì A, Osella G, Reimondo G, Bovio S, Daffara F, Procopio M, Paccotti P, Borretta G, Angeli A. J Clin Endocrinol Metab; 2002 Mar 20; 87(3):998-1003. PubMed ID: 11889151 [Abstract] [Full Text] [Related]
9. Is diabetes in Cushing's syndrome only a consequence of hypercortisolism? Giordano C, Guarnotta V, Pivonello R, Amato MC, Simeoli C, Ciresi A, Cozzolino A, Colao A. Eur J Endocrinol; 2014 Feb 20; 170(2):311-9. PubMed ID: 24255133 [Abstract] [Full Text] [Related]
10. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol]. Robaczyk MG. Ann Acad Med Stetin; 2002 Feb 20; 48():283-300. PubMed ID: 14601484 [Abstract] [Full Text] [Related]
11. Insulin action and hepatic glucose cycling in Cushing's syndrome. Heaney AP, Harper R, Ennis C, Rooney DP, Sheridan B, Atkinson AB, Bell PM. Clin Endocrinol (Oxf); 1997 Jun 20; 46(6):735-43. PubMed ID: 9274705 [Abstract] [Full Text] [Related]
12. Hormonal and metabolic rhythms in Cushing's syndrome. Johnston DG, Alberti KG, Nattrass M, Barnes AJ, Bloom SR, Joplin GF. Metabolism; 1980 Oct 20; 29(11):1046-52. PubMed ID: 7001175 [Abstract] [Full Text] [Related]
13. Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. Tauchmanovà L, Rossi R, Biondi B, Pulcrano M, Nuzzo V, Palmieri EA, Fazio S, Lombardi G. J Clin Endocrinol Metab; 2002 Nov 20; 87(11):4872-8. PubMed ID: 12414841 [Abstract] [Full Text] [Related]
15. Visfatin levels do not change after the oral glucose tolerance test and after a dexamethasone-induced increase in insulin resistance in humans. Marcinkowska M, Lewandowski KC, Lewiński A, Bieńkiewicz M, Basińska-Lewandowska M, Salata I, Randeva HS. Endokrynol Pol; 2007 Apr 20; 58(3):188-94. PubMed ID: 17940983 [Abstract] [Full Text] [Related]
16. The effect of glucocorticoid on 125I-insulin binding to human erythrocytes. Possible postreceptor modulation of receptor binding. Lee KU, Kim SY, Lee HK, Min HK. Diabetes Res Clin Pract; 1985 Dec 20; 1(4):211-20. PubMed ID: 3915263 [Abstract] [Full Text] [Related]
17. Insulin resistance in Cushing's disease. Evaluation by studies of insulin binding to erythrocytes. Wajchenberg BL, Leme CE, Lerario AC, Toledo e Souza IT, Rodbard HW, Rodbard D. Diabetes; 1984 May 20; 33(5):455-9. PubMed ID: 6373454 [Abstract] [Full Text] [Related]
18. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas. Katznelson L, Bogan JS, Trob JR, Schoenfeld DA, Hedley-Whyte ET, Hsu DW, Zervas NT, Swearingen B, Sleeper M, Klibanski A. J Clin Endocrinol Metab; 1998 May 20; 83(5):1619-23. PubMed ID: 9589666 [Abstract] [Full Text] [Related]
19. Insulin resistance in Cushing's syndrome. Nosadini R, Del Prato S, Tiengo A, Valerio A, Muggeo M, Opocher G, Mantero F, Duner E, Marescotti C, Mollo F, Belloni F. J Clin Endocrinol Metab; 1983 Sep 20; 57(3):529-36. PubMed ID: 6348064 [Abstract] [Full Text] [Related]
20. [ACTH secretion and adrenocortical responsiveness in Cushing's syndrome due to adrenocortical hyperplasia (author's transl)]. Suzuki S. Nihon Naibunpi Gakkai Zasshi; 1976 Aug 20; 52(8):828-44. PubMed ID: 190054 [Abstract] [Full Text] [Related] Page: [Next] [New Search]